Results 51 to 60 of about 81,119 (304)

Prevalence and factors associated with pre-exposure prophylaxis awareness among cisgender women of reproductive age in Burkina Faso

Women's Health
Background: HIV remains a global public health concern, and women continue to be disproportionately affected. Understanding the factors associated with pre-exposure prophylaxis awareness among women is crucial as an effective HIV prevention strategy ...
Michael Ekholuenetale, Semiu Adebayo Rahman, Chimezie Igwegbe Nzoputam, Osaretin Godspower Okungbowa, Amadou Barrow   +4 more
doaj   +1 more source

Assessment of acceptance and associated factors of HIV pre-exposure prophylaxis among commercial female sex workers in drop-in centers selected sub-cities of Addis Ababa, Ethiopia

Frontiers in Public Health
BackgroundGlobally, female sex workers (FSWs) face high risk of HIV, particularly in regions like sub-Saharan Africa. In Ethiopia and Addis Ababa, the impact is significant.
Trhas Tadesse Berhe, Elefie Asfaw Asfaw, Getachew Weldyohanes Tedla   +2 more
doaj   +1 more source

Perceptions about HIV pre-exposure prophylaxis among healthcare professionals in Spain (PERPPRES Study) [PDF]

Farmacia Hospitalaria, 2016
Objective: To determine the level of support, knowledge and perceptions of pre-exposure prophylaxis (PrEP) by Infectious Disease Specialists and Hospital Pharmacists in Spain.
Javier Sánchez-Rubio Ferrández, José Manuel Martínez Sesmero, Herminia Navarro Aznárez, Sergio Fernández Espínola, Ismael Escobar Rodríguez, José Manuel Ventura Cerdá   +5 more
doaj   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Advanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo   +3 more
wiley   +1 more source

Pre-Exposure Prophylaxis for HIV Prevention: Safety Concerns [PDF]

Drug Safety, 2017
Available evidence supports the efficacy of pre-exposure prophylaxis (PrEP) in decreasing the incidence of human immunodeficiency virus (HIV) infection among high-risk individuals, especially when used in combination with other behavioural preventive methods. Safety concerns about PrEP present challenges in the implementation and use of PrEP.
Tetteh, Raymond A, Yankey, Barbara A, Nartey, Edmund T, Lartey, Margaret, Leufkens, Hubert G M, Dodoo, Alexander N O   +5 more
openaire   +3 more sources

Choosing a metric for measurement of pre-exposure prophylaxis [PDF]

The Lancet Infectious Diseases, 2014
As the results of HIV prevention trials transition to public health practice, Susan Buchbinder and colleagues1 have provided a timely exploration of how to prioritise the targeting of pre-exposure prophylaxis (PrEP) to men who have sex with men (MSM). They have drawn attention to the need to examine the efficiency of PrEP in seroconversion prevention ...
Ruth, Emerson, Sarah, Emerson, Deborah, Donnell, James P, Hughes   +3 more
openaire   +5 more sources

Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure Prophylaxis

Frontiers in Pharmacology, 2019
Background: In Australia, clinical trial drugs are conventionally dispensed through clinical trial pharmacies only, while community pharmacies dispense drugs approved by Australia’s regulatory body.
Luxi Lal, Luxi Lal, Luxi Lal, Kathleen Ryan, Kathleen Ryan, Iris Yi Liu, Brian Price, Timmy Lockwood, Ivette Aguirre, Peter Slobodian, Ada Lam, Manoj Vassan, Kie Lim, John Silverii, Joseph Tesoriero, Johnny Phu, Wan Lim, Bharathy Naidoo, Nick Russell, Matthew Rundle, Rowan Sewell, Craig Cooper, Alexander Hardman, Martin Quinn, Anne Mak, Edwina J. Wright, Edwina J. Wright, Edwina J. Wright, Edwina J. Wright   +28 more
doaj   +1 more source

Pre-exposure prophylaxis (PrEP) and ‘risk’ in the news [PDF]

Journal of Risk Research, 2021
This study investigates ‘risk’ as discussed in news coverage and in relation to pre-exposure prophylaxis (PrEP): a treatment that has been proven to restrict the transmission of the human immunodef...
openaire   +3 more sources

Nanocellulose Alleviates Intrahepatic Cholestasis of Pregnancy via Gut Microbiota‐Mediated Bile Acid Homeostasis

Advanced Science, EarlyView.
Nanocellulose, derived from microcrystalline cellulose (MCC) through sulfuric acid hydrolysis or mechanical grinding to produce CNC or CNF, was tested in a rat ICP model. Particularly, CNF improved gut microbiota composition, reduced secondary bile acid metabolism, and restored bile acid homeostasis through modulation of the gut–liver axis.
Muhua Yu, Hongjie Dai, Xiaocui Zhong, Qibin Li, Hui Yuan, Yang Yang, Daiyong Huang, Lei Zhang, Rui Ran, Tian He, Yuanzhi Huang, Silas Villas‐Boas, Sergey Tumanov, Richard D. Cannon, Boris Novakovic, Richard Saffery, Yuhao Zhang, Xiaojing Dong, Ting‐Li Han   +18 more
wiley   +1 more source

Pre-exposure prophylaxis (PrEP) in Australia: are there challenges facing sexual health promotion?

, 2022
Pre-exposure prophylaxis (PrEP) in Australia: are there challenges facing sexual health ...
Anthony Barnett (3457076), Fiona McKay (13069920), Matthew Dunn (13067364)   +2 more
core